好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Lacosamide in the Management of Patients with Malignant Primary Brain Tumors
Neuro-oncology
(-)
022
Authors/Disclosures
Michael J. Schneck, MD, FAAN (Loyola University Chicago, Stritch School of Medicine) An immediate family member of Dr. Schneck has received personal compensation for serving as an employee of Cellcarta. Dr. Schneck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for HLT Medical. Dr. Schneck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Miscellaneous legal firms. Dr. Schneck has stock in Baxter Labs. The institution of Dr. Schneck has received research support from NIH.
Caroline Agha, MD No disclosure on file
No disclosure on file
Maria E. Baldwin, MD Dr. Baldwin has nothing to disclose.
Ludwig Kappos, MD, FAAN (RC2NB, University Hospital Basel) Dr. Kappos has nothing to disclose.
No disclosure on file
Jorge Asconape, MD (Loyola University Chicago) Dr. Asconape has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Asconape has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Lifesciences.
Vikram Prabhu Vikram Prabhu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zeiss.